Boron-containing compounds as labels, drugs, and theranostic agents for diabetes and its complications

doi:10.4239/wjd.v15.i6.1060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (418)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

349

Figures (1-3)

Tables (1-1)

Sum=400

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Jun 15, 2024 (publication date) through Jun 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Jun 15, 2024; 15(6): 1060-1069
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1060

Full Size Figure Download Figure

Figure 2 Examples of boron-containing compounds (on the right) whose activity parallels that of current drugs (on the left) for diabetes treatment. BODIPY: Boronodipyrromethene.

Citation: Soriano-Ursúa MA, Cordova-Chávez RI, Farfan-García ED, Kabalka G. Boron-containing compounds as labels, drugs, and theranostic agents for diabetes and its complications. World J Diabetes 2024; 15(6): 1060-1069
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1060.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1060